was read the article
array:25 [ "pii" => "S2173580817300986" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2015.03.020" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "743" "copyright" => "Sociedad Española de Neurología" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2017;32:463-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1591 "formatos" => array:3 [ "EPUB" => 63 "HTML" => 1188 "PDF" => 340 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0213485315000638" "issn" => "02134853" "doi" => "10.1016/j.nrl.2015.03.011" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "743" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2017;32:463-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3297 "formatos" => array:3 [ "EPUB" => 86 "HTML" => 2402 "PDF" => 809 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Modificaciones epigenéticas en neurología: alteraciones en la metilación del ADN en la esclerosis múltiple" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "463" "paginaFinal" => "468" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Epigenetic changes in neurology: DNA methylation in multiple sclerosis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1060 "Ancho" => 1643 "Tamanyo" => 89867 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Metilación del ADN: representación esquemática de la ruta metabólica implicada en la metilación del ADN. DNMT: DNA metiltransferasa; HC: homocisteina; MAT: metionina adenosiltrasferasa; Met: metionina; SAH: S-adenosilhomocisteina; SAHH: sadenosilhomocisteina hidrolasa; SAM: S-adenosilmetionina; THF: tetrahidrofolato; 5-MTHF: 5-metilentetrahidrofolato.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Iridoy Zulet, L. Pulido Fontes, T. Ayuso Blanco, F. Lacruz Bescos, M. Mendioroz Iriarte" "autores" => array:5 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Iridoy Zulet" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Pulido Fontes" ] 2 => array:2 [ "nombre" => "T." "apellidos" => "Ayuso Blanco" ] 3 => array:2 [ "nombre" => "F." "apellidos" => "Lacruz Bescos" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Mendioroz Iriarte" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173580817300986" "doi" => "10.1016/j.nrleng.2015.03.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580817300986?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485315000638?idApp=UINPBA00004N" "url" => "/02134853/0000003200000007/v1_201708280004/S0213485315000638/v1_201708280004/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2173580817300652" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2015.06.018" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "768" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2017;32:469-75" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 929 "formatos" => array:3 [ "EPUB" => 65 "HTML" => 627 "PDF" => 237 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Ethical considerations in presymptomatic diagnosis of autosomal dominant spinocerebellar ataxias" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "469" "paginaFinal" => "475" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Consideraciones éticas en el diagnóstico presintomático de ataxias espinocerebelosas autosómico dominantes" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.H. Orozco-Gutiérrez, I. Cervantes-Aragón, D. García-Cruz" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M.H." "apellidos" => "Orozco-Gutiérrez" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Cervantes-Aragón" ] 2 => array:2 [ "nombre" => "D." "apellidos" => "García-Cruz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485315001553" "doi" => "10.1016/j.nrl.2015.06.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485315001553?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580817300652?idApp=UINPBA00004N" "url" => "/21735808/0000003200000007/v1_201708280004/S2173580817300652/v1_201708280004/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2173580817301074" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2016.02.005" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "871" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Neurologia. 2017;32:455-62" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 901 "formatos" => array:3 [ "EPUB" => 69 "HTML" => 626 "PDF" => 206 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Descriptive study of symptomatic epilepsy by age of onset in patients with a 3-year follow-up at the Neuropaediatric Department of a reference centre" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "455" "paginaFinal" => "462" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio descriptivo de las epilepsias sintomáticas según edad de inicio controladas durante 3 años en una Unidad de Neuropediatría de referencia regional" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L. Ochoa-Gómez, J. López-Pisón, C. Fuertes-Rodrigo, R. Fernando-Martínez, P. Samper-Villagrasa, L. Monge-Galindo, J.L. Peña-Segura, M.C. García-Jiménez" "autores" => array:8 [ 0 => array:2 [ "nombre" => "L." "apellidos" => "Ochoa-Gómez" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "López-Pisón" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Fuertes-Rodrigo" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Fernando-Martínez" ] 4 => array:2 [ "nombre" => "P." "apellidos" => "Samper-Villagrasa" ] 5 => array:2 [ "nombre" => "L." "apellidos" => "Monge-Galindo" ] 6 => array:2 [ "nombre" => "J.L." "apellidos" => "Peña-Segura" ] 7 => array:2 [ "nombre" => "M.C." "apellidos" => "García-Jiménez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485316001195" "doi" => "10.1016/j.nrl.2016.02.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485316001195?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580817301074?idApp=UINPBA00004N" "url" => "/21735808/0000003200000007/v1_201708280004/S2173580817301074/v1_201708280004/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Epigenetic changes in neurology: DNA methylation in multiple sclerosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "463" "paginaFinal" => "468" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Iridoy Zulet, L. Pulido Fontes, T. Ayuso Blanco, F. Lacruz Bescos, M. Mendioroz Iriarte" "autores" => array:5 [ 0 => array:3 [ "nombre" => "M." "apellidos" => "Iridoy Zulet" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "L." "apellidos" => "Pulido Fontes" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "T." "apellidos" => "Ayuso Blanco" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "F." "apellidos" => "Lacruz Bescos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:4 [ "nombre" => "M." "apellidos" => "Mendioroz Iriarte" "email" => array:1 [ 0 => "tmendioi@navarra.es" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Navarrabiomed-Fundación Miguel Servet, Pamplona, Navarra, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Modificaciones epigenéticas en neurología: alteraciones en la metilación del ADN en la esclerosis múltiple" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1060 "Ancho" => 1643 "Tamanyo" => 87048 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">DNA methylation: diagram of the metabolic pathway involved in DNA methylation. DNMT: DNA methyltransferases; HC: homocysteine, MAT: methionine adenosyltransferase; MET: methionine; SAH: S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-homocysteine; SAHH: S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-homocysteine hydrolase; SAM: S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-methionine; THF: tetrahydrofolate; 5-MTHF: 5-methyltetrahydrofolate.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Introduction</span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Epigenetic regulatory mechanisms</span><p id="par0005" class="elsevierStylePara elsevierViewall">The term “epigenetics” appeared in the literature for the first time in the mid-20th century (Conrad Waddington, 1905-1975),<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">1</span></a> but it was not until recently that it has become an emerging research field. It is now considered a promising source of knowledge, especially in the medical field.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Epigenetics is the study of mechanisms regulating gene expression without modifying the deoxyribonucleic acid (DNA) sequence. This discipline represents a link between genetic and environmental influences on phenotype development. Epigenetic changes modify the activation of some genes depending on external conditions, and they are essential in cellular and tissue differentiation, which takes place during foetal development. These changes also occur during adulthood. Human cells experience epigenetic changes during their lifetimes. In fact, identical twins (with the same genetic load) accumulate different epigenetic patterns depending on the environmental factors to which they are exposed, for example, tobacco, diet, or exercise.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">2</span></a> This translates into observable differences in the phenotypes of both twins, which manifest as different susceptibilities to disease or disease outcomes.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The main epigenetic mechanisms involve DNA methylation, histone modification, and the action of non-coding RNA. DNA methylation is the best-known mechanism and its association with the development of diseases has been the subject of many studies. This mechanism is the focus of our study.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">DNA methylation</span><p id="par0020" class="elsevierStylePara elsevierViewall">DNA methylation is a process by which methyl groups are added to cytosine residues in the RNA nucleotide chain. This binding occurs at cytosine-guanine dinucleotides (CpG), which accumulate in the genome to form CpG islands. These islands are especially abundant in gene promoter regions and other regulatory regions. Methylation is carried out by DNA methyltransferases (DNMT) that catalyse the transfer of a methyl group from S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-methionine (SAM) to carbon 5 of cytosine.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">4</span></a> This process may follow one of 2 models: establishing a de novo DNA methylation pattern catalysed by DNMT3a and DNMT3b,<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">5</span></a> or maintaining a genomic methylation pattern through successive DNA replication cycles mediated by DNMT1. Methylation occurs during DNA replication such that when a CpG sequence adopts a certain methylation pattern, this modification becomes stable, and therefore inherited during DNA replication and maintained in daughter strands.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">6</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Hypermethylation at CpG islands in gene promoter regions is typically a gene repression mechanism since it inhibits transcription. This inhibition takes place through 2 processes: a direct one which prevents binding of transcription factors containing recognition sites for methylated CpG, and an indirect one, which blocks the access to regulatory elements, necessary for transcription factor binding, by adhering protein complexes known as methyl-binding domains (MBD), which bind to methylated CpG sites.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">7</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">As explained before, the SAM molecule is the methyl group donor; this molecule becomes S-Adenosyl-<span class="elsevierStyleSmallCaps">l</span>-homocysteine (SAH) after losing the methyl group. SAM is hydrolised to homocysteine and subsequently remethylated to methionine by 5-methyltetrahydrofolate cofactor (5-MTHF). Methionine is finally transformed into a SAM molecule by methionine adenosyltransferase (MAT) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). The potential of DNA methylation will depend on the ratio between SAM level and SAH in blood. The higher the ratio, the greater the potential of DNA methylation.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">8</span></a> We can therefore state that DNA methylation requires proper metabolism of homocysteine, methionine, other enzymes involved in this metabolic pathway, and such substances as folic acid and vitamin B<span class="elsevierStyleInf">12</span>.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">9</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Significance of DNA methylation in clinical practice</span><p id="par0035" class="elsevierStylePara elsevierViewall">The link between alterations in epigenetic mechanisms and human disease has become an emerging line of research in recent years; evidence of such an association has been reported in several diseases, especially in the field of oncology. The first type of tumour to be associated with epigenetic regulatory mechanisms was colorectal cancer (CRC). A loss of overall methylation was initially observed in cancer cells of patients with CRC compared to those of healthy controls.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">10</span></a> At the same time, promoters of tumour suppressor genes were found to be methylated, leading to decreased expression of those genes.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">11</span></a> These findings supported the association between hypermethylation of tumour suppressor genes and disease development.</p><p id="par0040" class="elsevierStylePara elsevierViewall">However, in other medical fields such as neurological diseases, the role disrupted DNA methylation plays in disease development is yet to be understood. In the specific case of multiple sclerosis (MS), epigenetic changes potentially involved in disease pathogenesis have recently been found, opening up a new and interesting line of research.</p><p id="par0045" class="elsevierStylePara elsevierViewall">MS is considered the leading cause of severe neurological impairment in young and middle-aged adults. In Spain, prevalence studies report rates of around 80 cases per 100<span class="elsevierStyleHsp" style=""></span>000 population. MS is a chronic disease causing inflammatory, demyelinating, neurodegenerative lesions to the central nervous system (CNS). Although its aetiology is still unknown, MS is believed to have an autoimmune, probably multifactorial origin associated with a number of genetic and environmental susceptibility factors. In view of the complexity of MS and the multiple aetiological mechanisms (both genetic and environmental) involved in MS pathogenesis, we may hypothesise that altered epigenetic regulation may be involved in MS.<a class="elsevierStyleCrossRefs" href="#bib0300"><span class="elsevierStyleSup">12,13</span></a></p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Risk factors and epigenetic changes in multiple sclerosis</span><p id="par0050" class="elsevierStylePara elsevierViewall">Epidemiological and familial aggregation studies suggest a genetic predisposition to MS. To date, however, the only locus consistently found to be linked to MS is the major histocompatibility complex (MHC). This predisposition has been linked to the DR2 haplotype (HLA-DRB1*1501-DQA1*0102-DQB1*0602), which is associated with a relative risk of MS of 4.<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">14</span></a> The development of new techniques, such as polymorphism arrays, has led to the identification of new candidate genes located outside the MHC region. MS is a polygenic disease in which each of the associated genes present a different risk of developing the disease (normally low to moderate risk).<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">15</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">The role of genetic susceptibility factors in MS is therefore clear; however, environmental factors causing epigenetic changes seem to be essential in MS development.<a class="elsevierStyleCrossRefs" href="#bib0320"><span class="elsevierStyleSup">16,17</span></a> We will now list the 3 environmental risk factors of MS described in the literature and analyse their impact on epigenetic regulation in MS and other diseases.<a class="elsevierStyleCrossRefs" href="#bib0330"><span class="elsevierStyleSup">18,19</span></a></p><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Smoking and epigenetic mechanisms</span><p id="par0060" class="elsevierStylePara elsevierViewall">As shown in multiple studies,<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">20,21</span></a> smoking is one of the main environmental factors involved in progression of MS. In fact, smoking has been linked to increased frequency of relapses and a greater number of active brain lesions in MRI in patients with MS.<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">22</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">A study analysing blood samples from adolescents whose mothers smoked during pregnancy found an association between prenatal exposure to tobacco and increased methylation of the brain derived neurotrophic factor (BDNF) promoter, which promotes differentiation and growth of new neurons.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">23</span></a> Suter et al.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">24</span></a> compared DNA methylation patterns in smokers and non-smokers using PCR tests. They found DNA methylation changes in 25 genes in non-smokers and in 438 genes in smokers.<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">24</span></a> Epigenetic changes linked to smoking have also been found in studies of patients with cancer. In a study including patients with lung cancer, smokers exhibited hypermethylation of the <span class="elsevierStyleItalic">CDKN2A</span>, <span class="elsevierStyleItalic">DAPK</span>, and <span class="elsevierStyleItalic">MGMT</span> tumour suppressor genes.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">25</span></a> Likewise, a study of cervical cancer in women aged 15-19 years also observed hypermethylation of the <span class="elsevierStyleItalic">CDKN2A</span> gene in cervical epithelial cells of smokers.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">26</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Vitamin D and epigenetic changes</span><p id="par0070" class="elsevierStylePara elsevierViewall">Vitamin D deficiency is one of the most influential risk factors in the development of MS.<a class="elsevierStyleCrossRefs" href="#bib0375"><span class="elsevierStyleSup">27–29</span></a> Vitamin D is a powerful regulator of inflammatory and immunoregulatory response, acting on both innate and adaptive immunity.<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">30</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Although the mechanism by which vitamin D causes such changes remains unknown, the results of a study conducted by Joshi et al.<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">31</span></a> suggest that it may be due to epigenetic changes. This study analyses the effects of 1,25(OH)2D3 (active form of vitamin D produced by the skin after exposure to ultraviolet light) on IL-17A production by CD4+ T-cells in humans. Researchers observed that 1,25(OH)<span class="elsevierStyleInf">2</span>D<span class="elsevierStyleInf">3</span> directly inhibits IL-17, which is responsible for the transcription of proinflammatory cytokines by modifying histone deacetylase 2 (HDAC2) in the IL17A promoter region.<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">31</span></a> Previous studies have shown that vitamin D is able to cause epigenetic changes, as in the case of CRC, where 1,25(OH)<span class="elsevierStyleInf">2</span>D<span class="elsevierStyleInf">3</span> has been observed to induce expression of the gene coding for lysine-specific demethylase (<span class="elsevierStyleItalic">JMJD3</span>).<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">32</span></a></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Epstein–Barr virus (EBV) and epigenetic mechanisms</span><p id="par0080" class="elsevierStylePara elsevierViewall">To date, several infectious agents have been serologically and pathologically linked to MS. One example is the study by Sundstrom et al.,<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">33</span></a> which analyses evidence supporting the presence of a viral infection in the presymptomatic stage of MS. However, only EBV nuclear antigens displayed a direct pathological correlation with onset of MS.<a class="elsevierStyleCrossRefs" href="#bib0405"><span class="elsevierStyleSup">33,34</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Thus, EBV infection has been linked to epigenetic changes in the infected cells. Several types of tumours have been associated with EBV infection due to hypermethylation of tumour suppressor gene promoters,<a class="elsevierStyleCrossRef" href="#bib0415"><span class="elsevierStyleSup">35</span></a> as in the case of nasopharyngeal cancer or EBV-induced Hodgkin lymphoma, where hypermethylation of the promoter has been found to be caused by an increase in DNMT1, DNMT 3 a, and DNMT 3 b enzymes, mediated through viral protein LMP1.<a class="elsevierStyleCrossRef" href="#bib0420"><span class="elsevierStyleSup">36</span></a> Epigenetic changes associated with EBV in MS are also linked to microRNA expression (miRNA). Expression of miR-142-3p in patients with MS has been linked to increased immune tolerance, while the expression of miRNA-155 is associated with greater T-cell differentiation and CNS inflammation.<a class="elsevierStyleCrossRef" href="#bib0425"><span class="elsevierStyleSup">37</span></a></p></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">DNA methylation in multiple sclerosis</span><p id="par0090" class="elsevierStylePara elsevierViewall">The precise pathophysiological mechanisms mediating between environmental risk factors and susceptibility to develop MS remain unknown.<a class="elsevierStyleCrossRef" href="#bib0430"><span class="elsevierStyleSup">38</span></a> In this context, DNA methylation may provide new insights.</p><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Inflammation and DNA methylation</span><p id="par0095" class="elsevierStylePara elsevierViewall">Over the past few years, numerous authors have linked the degree of methylation in specific genes to presence of MS. Kumagai et al.<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">39</span></a> observed that the tyrosine phosphatase (SHP-1) promoter, a negative regulator of proinflammatory signalling, is hypomethylated in patients with MS compared to healthy controls. Methylation of the SHP-1 promoter results in decreased SHP-1 expression and consequently greater lymphocyte-mediated inflammatory activity.<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">39</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">Janson et al.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">40</span></a> analysed CD4<span class="elsevierStyleSup">+</span> T cells in a series of patients with relapsing-remitting MS (RRMS). According to their findings, these patients displayed demethylation of <span class="elsevierStyleItalic">FOXP3</span>, a gene coding for scurfin (scurfin deficiency is associated with autoimmune diseases). <span class="elsevierStyleItalic">FOXP3</span> demethylation may inhibit Th1 and Th2 cell differentiation while promoting regulatory T cells (Treg) and Th17 cells. Th1/Th2 and Treg/Th17 balance has an impact on the disease; imbalance may therefore result in new lesions or lesion repair. DNA methylation is precisely one of the factors regulating this balance.<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">40,41</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Other researchers report hypomethylation of the promoter of the gene coding for IL-17A, a proinflammatory cytokine secreted exclusively by activated T cells; hypomethylation has been associated with the development of autoimmune diseases and plays an essential role in MS pathogenesis.<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">42</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Demyelination and DNA methylation</span><p id="par0110" class="elsevierStylePara elsevierViewall">According to a study by Mastronardi et al.,<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">43</span></a> the peptidyl arginine deiminase 2 (PAD-2) promoter is demethylated and PAD-2 is consequently overexpressed in the brain during white matter demyelination in patients with MS. PAD-2 leads to loss of myelin basic protein (MBP) stability as a consequence of the enzymatic conversion of arginine into citrulline. Citrullination causes the MBP to act as an antigen for T cells. PAD-2 promoter methylation in white matter is decreased by 25% in patients with MS compared to healthy controls. These changes are present in patients with MS but have not been observed in patients with such other neurological diseases as Alzheimer disease, Parkinson's disease, and Huntington disease.<a class="elsevierStyleCrossRef" href="#bib0455"><span class="elsevierStyleSup">43</span></a></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Neurodegeneration and DNA methylation</span><p id="par0115" class="elsevierStylePara elsevierViewall">To date, no studies have specifically analysed the role of epigenetic mechanisms in neurodegeneration in patients with MS. Nevertheless, some studies have addressed the changes in DNA methylation occurring during neuronal death. Chestnut et al.<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">44</span></a> analysed cells from patients with amyotrophic lateral sclerosis and observed that overexpression of the DNMT3a enzyme induces cell degeneration and death whereas DNMT3a inhibition protects neurons. In fact, DNA methylation regulates DNMT3a expression. The above suggests that such a mechanism may be involved in neurodegeneration in patients with MS.</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Conclusions</span><p id="par0120" class="elsevierStylePara elsevierViewall">Multiple sclerosis is a neurological disease with a considerable healthcare, social, and family burden. Despite recent advances in our understanding of MS, the exact aetiopathogenic mechanisms of the disease are yet to be determined and no curative treatment has been developed to date.</p><p id="par0125" class="elsevierStylePara elsevierViewall">Epigenetic changes, such as DNA methylation, constitute a mechanism enabling environmental factors to affect individual gene expression. Epigenetics represents an interesting line of research in the medical field, especially in the case of diseases in which environmental risk factors may play a role, as in MS.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Despite the limited number of published studies of patients with MS, results encourage further research into this area. Currently available data point to a relationship between autoimmune diseases and regulation of DNA methylation in candidate genes, which are key to the development of MS.<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">45,46</span></a> Despite mounting evidence of this association, further studies with larger patient and control groups should be conducted.<a class="elsevierStyleCrossRefs" href="#bib0475"><span class="elsevierStyleSup">47,48</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">Knowledge of the epigenetic changes involved in the pathogenesis of MS will help us understand the pathogenic mechanisms of the disease, paving the way for the identification of potential biomarkers and new therapeutic targets.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conflicts of interest</span><p id="par0140" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres887287" "titulo" => "Abstract" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Development" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec873239" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres887288" "titulo" => "Resumen" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Desarrollo" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusión" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec873238" "titulo" => "Palabras clave" ] 4 => array:3 [ "identificador" => "sec0005" "titulo" => "Introduction" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0010" "titulo" => "Epigenetic regulatory mechanisms" ] 1 => array:2 [ "identificador" => "sec0015" "titulo" => "DNA methylation" ] 2 => array:2 [ "identificador" => "sec0020" "titulo" => "Significance of DNA methylation in clinical practice" ] ] ] 5 => array:3 [ "identificador" => "sec0025" "titulo" => "Risk factors and epigenetic changes in multiple sclerosis" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0030" "titulo" => "Smoking and epigenetic mechanisms" ] 1 => array:2 [ "identificador" => "sec0035" "titulo" => "Vitamin D and epigenetic changes" ] 2 => array:2 [ "identificador" => "sec0040" "titulo" => "Epstein–Barr virus (EBV) and epigenetic mechanisms" ] ] ] 6 => array:3 [ "identificador" => "sec0045" "titulo" => "DNA methylation in multiple sclerosis" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0050" "titulo" => "Inflammation and DNA methylation" ] 1 => array:2 [ "identificador" => "sec0055" "titulo" => "Demyelination and DNA methylation" ] 2 => array:2 [ "identificador" => "sec0060" "titulo" => "Neurodegeneration and DNA methylation" ] ] ] 7 => array:2 [ "identificador" => "sec0065" "titulo" => "Conclusions" ] 8 => array:2 [ "identificador" => "sec0070" "titulo" => "Conflicts of interest" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-01-29" "fechaAceptado" => "2015-03-05" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec873239" "palabras" => array:6 [ 0 => "Multiple sclerosis" 1 => "Epigenetics" 2 => "DNA methylation" 3 => "Vitamin D" 4 => "Smoking" 5 => "Epstein Barr virus" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec873238" "palabras" => array:6 [ 0 => "Esclerosis múltiple" 1 => "Epigenética" 2 => "Metilación del ADN" 3 => "Vitamina D" 4 => "Tabaco" 5 => "Virus Epstein Barr" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Epigenetics is defined as the study of the mechanisms that regulate gene expression without altering the underlying DNA sequence. The best known is DNA methylation. Multiple sclerosis (MS) is a disease with no entirely known aetiology, in which it is stated that the involvement of environmental factors on people with a genetic predisposition, may be key to the development of the disease. It is at this intersection between genetic predisposition and environmental factors where DNA methylation may play a pathogenic role.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Development</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A literature review of the effects of environmental risk factors for the development of MS can have on the different epigenetic mechanisms as well as the implication that such changes have on the development of the disease.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Conclusion</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Knowledge of epigenetic modifications involved in the pathogenesis of MS, opens a new avenue of research for identification of potential biomarkers, as well as finding new therapeutic targets.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Development" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Introducción</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">La epigenética se define como el estudio de los mecanismos que regulan la expresión génica sin modificar la secuencia de ADN, siendo entre ellos el más conocido la metilación del ADN. La esclerosis múltiple (EM) es una enfermedad de etiología no del todo conocida, en la que se plantea que la participación de factores ambientales sobre individuos con una determinada predisposición genética, pueden resultar claves para el desarrollo de la enfermedad. Es en esta intersección entre la predisposición genética y los factores ambientales donde la metilación del ADN puede desempeñar un papel patogénico.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Desarrollo</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Realizamos una revisión bibliográfica de los efectos que los factores de riesgo ambiental para el desarrollo de EM pueden ejercer sobre los distintos mecanismos epigenéticos, así como la implicación que presentan dichas modificaciones en el desarrollo de la enfermedad.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusión</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">El conocimiento de las modificaciones epigenéticas involucradas en la patogenia de la EM abre una nueva vía de investigación para la identificación de potenciales biomarcadores, así como para la búsqueda de nuevas dianas terapéuticas.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Desarrollo" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusión" ] ] ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Iridoy Zulet M, Pulido Fontes L, Ayuso Blanco T, Lacruz Bescos F, Mendioroz Iriarte M. Modificaciones epigenéticas en neurología: alteraciones en la metilación del ADN en la esclerosis múltiple. Neurología. 2017;32:463–468.</p>" ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">This study has not been presented at the SEN's Annual Meeting or at any other meetings or congresses. This study has received no public or private funding.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1060 "Ancho" => 1643 "Tamanyo" => 87048 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">DNA methylation: diagram of the metabolic pathway involved in DNA methylation. DNMT: DNA methyltransferases; HC: homocysteine, MAT: methionine adenosyltransferase; MET: methionine; SAH: S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-homocysteine; SAHH: S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-homocysteine hydrolase; SAM: S-adenosyl-<span class="elsevierStyleSmallCaps">l</span>-methionine; THF: tetrahydrofolate; 5-MTHF: 5-methyltetrahydrofolate.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:48 [ 0 => array:3 [ "identificador" => "bib0245" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A historical overview" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Holliday" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Epigenetics" "fecha" => "2006" "volumen" => "1" "paginaInicial" => "76" "paginaFinal" => "80" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17998809" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0250" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enviromental and nutritional effects on the epigenetic regulation of genes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Feil" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Mutat Res" "fecha" => "2006" "volumen" => "600" "paginaInicial" => "46" "paginaFinal" => "57" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0255" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic differences arise during the lifetime of monozygotic twins" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.F. Fraga" 1 => "E. Ballestar" 2 => "M.F. Paz" 3 => "S. Ropero" 4 => "F. Setien" 5 => "M.L. Ballestar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.0500398102" "Revista" => array:6 [ "tituloSerie" => "Proc Natl Acad Sci U S A" "fecha" => "2005" "volumen" => "102" "paginaInicial" => "10604" "paginaFinal" => "10609" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16009939" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0260" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metilación del ADN: un fenómeno epigenético de importancia médica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Rodríguez-Dorantes" 1 => "N. Téllez-Ascencio" 2 => "M.A. Cerbón" 3 => "M. López" 4 => "A. Cervantes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Invest Clin" "fecha" => "2004" "volumen" => "56" "paginaInicial" => "56" "paginaFinal" => "71" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15144044" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0265" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of mammalian DNA methyltransferases in the regulation of gene expression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Turek-Plewa" 1 => "P.P. Jagodziński" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cell Mol Biol Lett" "fecha" => "2005" "volumen" => "10" "paginaInicial" => "631" "paginaFinal" => "647" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16341272" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0270" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An insight into the various regulatory mechanisms modulating human DNA methyltrasnferases stability and function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Kar" 1 => "M. Deb" 2 => "D. Sengupta" 3 => "A. Shilpi" 4 => "S. Parbin" 5 => "J. Torrisani" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4161/epi.21568" "Revista" => array:7 [ "tituloSerie" => "Epigenetics" "fecha" => "2012" "volumen" => "7" "paginaInicial" => "994" "paginaFinal" => "1007" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22894906" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0923181115000389" "estado" => "S300" "issn" => "09231811" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0275" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic mechanisms in neurological diseases: genes, syndromes and therapies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R.G. Urdinguio" 1 => "J.V. Sanchez-Mut" 2 => "M. Esteller" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2009" "volumen" => "8" "paginaInicial" => "1598" "paginaFinal" => "1609" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0280" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "One-carbon metabolism in psychiatric illness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Sugden" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1079/NRR2006119" "Revista" => array:6 [ "tituloSerie" => "Nutr Res Rev" "fecha" => "2006" "volumen" => "19" "paginaInicial" => "117" "paginaFinal" => "136" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19079880" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0285" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.A. Fryer" 1 => "R.D. Emes" 2 => "K.M. Ismail" 3 => "K.E. Haworth" 4 => "C. Mein" 5 => "W.D. Carroll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4161/epi.6.1.13392" "Revista" => array:7 [ "tituloSerie" => "Epigenetics" "fecha" => "2011" "volumen" => "6" "paginaInicial" => "86" "paginaFinal" => "94" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20864804" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0022202X1537086X" "estado" => "S300" "issn" => "0022202X" ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0290" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypomethylation distinguishes genes of some human cancers from their normal counterparts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.P. Feinberg" 1 => "B. Vogelstein" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "1983" "volumen" => "301" "paginaInicial" => "89" "paginaFinal" => "92" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6185846" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0295" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic profiling joins personalized cancer medicine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H. Heyn" 1 => "J. Méndez-González" 2 => "M. Esteller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1586/erm.13.36" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Mol Diagn" "fecha" => "2013" "volumen" => "13" "paginaInicial" => "473" "paginaFinal" => "479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23782254" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0300" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic alterations and autoimmune disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y. Renaudineau" 1 => "D. Beauvillard" 2 => "M. Padelli" 3 => "W.H. Brooks" 4 => "P. Youinou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1017/S2040174411000353" "Revista" => array:6 [ "tituloSerie" => "J Dev Orig Health Dis" "fecha" => "2011 Oct" "volumen" => "2" "paginaInicial" => "258" "paginaFinal" => "264" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25141262" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0305" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple sclerosis: current knowledge and future outlook" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C.P. Kamm" 1 => "B.M. Uitdehaag" 2 => "C.H. Polman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000360528" "Revista" => array:6 [ "tituloSerie" => "Eur Neurol" "fecha" => "2014" "volumen" => "72" "paginaInicial" => "132" "paginaFinal" => "141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25095894" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0310" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A second major histocompatibility complex susceptibility locus for multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.W. Yeo" 1 => "P.L. de Jager" 2 => "S.G. Gregory" 3 => "L.F. Barcellos" 4 => "A. Walton" 5 => "A. Goris" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.21063" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2007" "volumen" => "61" "paginaInicial" => "228" "paginaFinal" => "236" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17252545" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0315" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk alleles for multiple sclerosis indentified by a genomewide study" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "International Multiple Sclerosis Genetics Consortium" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa073493" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2007" "volumen" => "357" "paginaInicial" => "851" "paginaFinal" => "862" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17660530" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0320" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetics of multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.A. Dyment" 1 => "G.C. Ebers" 2 => "A.D. Sadovnick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2004" "volumen" => "3" "paginaInicial" => "104" "paginaFinal" => "110" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14747002" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0325" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Heavy metals, organic solvents and multiple sclerosis: an exploratory look at gene–environment interactions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.D. Napier" 1 => "C. Poole" 2 => "G.A. Satten" 3 => "A. Ashley-Koch" 4 => "R. Ann Marrie" 5 => "D.M. Williamson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/19338244.2014.937381" "Revista" => array:6 [ "tituloSerie" => "Arch Environ Occup Health" "fecha" => "2016" "volumen" => "71" "paginaInicial" => "26" "paginaFinal" => "34" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25137520" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0330" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Environmental factors and multiple sclerosis severity: a descriptive study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Mandia" 1 => "O.E. Ferraro" 2 => "G. Nosari" 3 => "C. Montomoli" 4 => "E. Zardini" 5 => "R. Bergamaschi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijerph110606417" "Revista" => array:6 [ "tituloSerie" => "Int J Environ Res Public Health" "fecha" => "2014" "volumen" => "11" "paginaInicial" => "6417" "paginaFinal" => "6432" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24950063" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0335" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tobacco smoking and excess mortality in multiple sclerosis: a cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Manouchehrinia" 1 => "M. Weston" 2 => "C.R. Tench" 3 => "J. Britton" 4 => "C.S. Constantinescu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "J Neurol Neurosurg Psychiatry" "fecha" => "2014" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0340" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio de casos y controles sobre la influencia del hábito tabáquico en la esclerosis múltiple" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Rodríguez Regal" 1 => "M. del Campo Amigo" 2 => "J. Paz-Esquete" 3 => "A. Martínez Feijoo" 4 => "E. Cebrián" 5 => "P. Suárez Gil" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Neurología" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "177180" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0345" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cigarette smoking and the progresion of multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.A. Hernán" 1 => "S.S. Jick" 2 => "G. Logroscino" 3 => "M.J. Olek" 4 => "A. Ascherio" 5 => "H. Jick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Brain" "fecha" => "2005" "volumen" => "128" "paginaInicial" => "146165" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0350" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Smoking and disease progression in multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B.C. Healy" 1 => "E.N. Ali" 2 => "C.R. Guttmann" 3 => "T. Chitnis" 4 => "B.I. Glanz" 5 => "G. Buckle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archneurol.2009.122" "Revista" => array:6 [ "tituloSerie" => "Arch Neurol" "fecha" => "2009" "volumen" => "66" "paginaInicial" => "858" "paginaFinal" => "864" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19597087" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0355" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotropic factor-6 exon in adolescent offspring" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Toledo-Rodriguez" 1 => "S. Lotfipour" 2 => "G. Leonard" 3 => "M. Perron" 4 => "L. Richer" 5 => "S. Veillette" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Med Genet B Neuropsychiat Genet" "fecha" => "2010" "volumen" => "13B" "paginaInicial" => "1350" "paginaFinal" => "1354" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0360" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.A. Suter" 1 => "A.M. Anders" 2 => "K.M. Aagaard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/molehr/gas050" "Revista" => array:6 [ "tituloSerie" => "Mol Hum Reprod" "fecha" => "2013" "volumen" => "19" "paginaInicial" => "1" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23139402" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0365" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of epigenetic events in chemical carcinogenesis—a justification for incorporating epigenetic evaluations in cancer risk assessment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "I. Koturbash" 1 => "F.A. Beland" 2 => "I.P. Pogribny" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Toxicol Mech Methods" "fecha" => "2011" "volumen" => "21" "paginaInicial" => "289" "paginaFinal" => "297" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0370" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y.T. Ma" 1 => "S.I. Collins" 2 => "L.S. Young" 3 => "P.G. Murray" 4 => "C.B. Woodman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/bjc.2011.113" "Revista" => array:6 [ "tituloSerie" => "Br J Cancer" "fecha" => "2011" "volumen" => "104" "paginaInicial" => "1500" "paginaFinal" => "1504" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21487403" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0375" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple sclerosis is associated with low previous ultraviolet radiation exposure and low levels of current vitamin D: no interaction with HLA complex genes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Baarnhielm" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Mult Scler" "fecha" => "2010" "volumen" => "16" "paginaInicial" => "S7" "paginaFinal" => "S39" "itemHostRev" => array:3 [ "pii" => "S0190962211010681" "estado" => "S300" "issn" => "01909622" ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0380" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Location and vitamin D synthesis: is the hypothesis validated by geophysical data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.G. Kimlin" 1 => "W.J. Olds" 2 => "M.R. Moore" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jphotobiol.2006.10.004" "Revista" => array:6 [ "tituloSerie" => "J Photochem Photobiol B" "fecha" => "2007" "volumen" => "86" "paginaInicial" => "234" "paginaFinal" => "239" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17142054" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0385" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Smolders" 1 => "E. Peelen" 2 => "M. Thewissen" 3 => "J.W. Cohen Tervaert" 4 => "P. Menheere" 5 => "R. Hupperts" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0015235" "Revista" => array:5 [ "tituloSerie" => "PLoS ONE" "fecha" => "2010" "volumen" => "5" "paginaInicial" => "e15235" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21179201" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0390" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cytokine profile in patients with multiple sclerosis following vitamin D supplementation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "B.D. Mahon" 1 => "S.A. Gordon" 2 => "J. Cruz" 3 => "F. Cosman" 4 => "M.T. Cantorna" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Neuroimmunol" "fecha" => "2003" "volumen" => "134" "paginaInicial" => "128" "paginaFinal" => "132" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12507780" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0395" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "1,25-Dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Joshi" 1 => "L.C. Pantalena" 2 => "X.K. Liu" 3 => "S.L. Gaffen" 4 => "H. Liu" 5 => "C. Rohowsky-Kochan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Moll Cell Biol" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "3653" "paginaFinal" => "3669" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0400" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vitamin D has wide regulatory effects on histone desmethylase genes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Pereira" 1 => "A. Barbáchano" 2 => "P.K. Singh" 3 => "M.J. Campbell" 4 => "A. Muñoz" 5 => "M.J. Larriba" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4161/cc.11.6.19508" "Revista" => array:6 [ "tituloSerie" => "Cell Cycle" "fecha" => "2012" "volumen" => "11" "paginaInicial" => "1081" "paginaFinal" => "1089" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22370479" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0405" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence for virus infections in the presymptomatic stage of MS" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Sundstrom" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Mult Scler" "fecha" => "2010" "volumen" => "16" "paginaInicial" => "S7" "paginaFinal" => "S39" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0410" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A.E. Handel" 1 => "A.J. Williamson" 2 => "G. Disanto" 3 => "L. Handunnetthi" 4 => "G. Giovannoni" 5 => "S.V. Ramagopalan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0015586" "Revista" => array:5 [ "tituloSerie" => "PLoS ONE" "fecha" => "2010" "volumen" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21203468" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S092318111500078X" "estado" => "S300" "issn" => "09231811" ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0415" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic dysregulation of the host cell genomein Epstein–Barr virus associated neoplasia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H.H. Niller" 1 => "H. Wolf" 2 => "J. Minarovits" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.semcancer.2009.02.012" "Revista" => array:6 [ "tituloSerie" => "Semin Cancer Biol" "fecha" => "2009" "volumen" => "19" "paginaInicial" => "158" "paginaFinal" => "164" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19429479" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0420" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH2-terminal kinase signaling" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.L. Tsai" 1 => "H.P. Li" 2 => "Y.J. Lu" 3 => "C. Hsueh" 4 => "Y. Liang" 5 => "C.L. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1158/0008-5472.CAN-06-2194" "Revista" => array:6 [ "tituloSerie" => "Cancer Res" "fecha" => "2006" "volumen" => "66" "paginaInicial" => "11668" "paginaFinal" => "11676" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17178861" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0425" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Junker" 1 => "M. Krumbholz" 2 => "S. Eisele" 3 => "H. Mohan" 4 => "F. Augstein" 5 => "R. Bittner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/brain/awp300" "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2009" "volumen" => "132" "paginaInicial" => "3342" "paginaFinal" => "3352" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19952055" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0430" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The inmmunology of multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Bar-Or" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-2007-1019124" "Revista" => array:7 [ "tituloSerie" => "Semin Neurol" "fecha" => "2008" "volumen" => "28" "paginaInicial" => "29" "paginaFinal" => "45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18256985" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0923181115000511" "estado" => "S300" "issn" => "09231811" ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0435" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Kumagai" 1 => "B. Kalman" 2 => "F.A. Middleton" 3 => "T. Vyshkina" 4 => "P.T. Massa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jneuroim.2012.03.003" "Revista" => array:6 [ "tituloSerie" => "J Neuroimmunol" "fecha" => "2012" "volumen" => "246" "paginaInicial" => "51" "paginaFinal" => "57" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22458980" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0440" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Profiling of CD4+ T cells with epigenetic immune lineage analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.C. Janson" 1 => "L.B. Linton" 2 => "E.A. Bergman" 3 => "P. Marits" 4 => "M. Eberhardson" 5 => "F. Piehl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4049/jimmunol.1000960" "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "2011" "volumen" => "186" "paginaInicial" => "92" "paginaFinal" => "102" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21131423" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0445" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Liggett" 1 => "A. Melnikov" 2 => "S. Tilwalli" 3 => "Q. Yi" 4 => "H. Chen" 5 => "C. Replogle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jns.2009.12.018" "Revista" => array:7 [ "tituloSerie" => "J Neurol Sci" "fecha" => "2010" "volumen" => "290" "numero" => "1-2" "paginaInicial" => "16" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20064646" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0450" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic changes in patients with multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.W. Koch" 1 => "L.M. Metz" 2 => "O. Kovalchuk" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Nature Rev Neurol" "fecha" => "2012" ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0455" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter ishypomethylated" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F.G. Mastronardi" 1 => "A. Noor" 2 => "D.D. Wood" 3 => "T. Paton" 4 => "M.A. Moscarello" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jnr.21329" "Revista" => array:6 [ "tituloSerie" => "J Neurosci Res" "fecha" => "2007" "volumen" => "85" "paginaInicial" => "2006" "paginaFinal" => "2016" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17469138" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0460" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic regulation of motor neuron cell death through DNA methylation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B.A. Chestnut" 1 => "Q. Chang" 2 => "A. Price" 3 => "C. Lesuisse" 4 => "M. Wong" 5 => "L.J. Martin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1523/JNEUROSCI.1639-11.2011" "Revista" => array:6 [ "tituloSerie" => "J Neurosci" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "16619" "paginaFinal" => "16636" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22090490" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0465" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Potential role of epigenetic modifications in the heritability of multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y. Zhou" 1 => "S. Simpson Jr." 2 => "A.F. Holloway" 3 => "J. Charlesworth" 4 => "I. van der Mei" 5 => "B.V. Taylor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1352458514520911" "Revista" => array:6 [ "tituloSerie" => "Mult Scler" "fecha" => "2014" "volumen" => "20" "paginaInicial" => "135" "paginaFinal" => "140" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24493701" "web" => "Medline" ] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0470" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.L. Huynh" 1 => "P. Casaccia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(12)70309-5" "Revista" => array:7 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2013" "volumen" => "12" "paginaInicial" => "195" "paginaFinal" => "206" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23332363" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0923181115000729" "estado" => "S300" "issn" => "09231811" ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0475" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associatedwith multiple sclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Graves" 1 => "M. Benton" 2 => "R. Lea" 3 => "M. Boyle" 4 => "L. Tajouri" 5 => "D. Macartney-Coxson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Mult Scler" "fecha" => "2013" "volumen" => "20" "paginaInicial" => "1033" "paginaFinal" => "1041" ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0480" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Huynh" 1 => "P. Garg" 2 => "T.H. Thin" 3 => "S. Yoo" 4 => "R. Dutta" 5 => "B.D. Trapp" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nn.3588" "Revista" => array:6 [ "tituloSerie" => "Nat Neurosci" "fecha" => "2014" "volumen" => "17" "paginaInicial" => "121" "paginaFinal" => "130" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24270187" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735808/0000003200000007/v1_201708280004/S2173580817300986/v1_201708280004/en/main.assets" "Apartado" => array:4 [ "identificador" => "9423" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735808/0000003200000007/v1_201708280004/S2173580817300986/v1_201708280004/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580817300986?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 8 | 2 | 10 |
2024 October | 54 | 3 | 57 |
2024 September | 54 | 3 | 57 |
2024 August | 51 | 6 | 57 |
2024 July | 31 | 3 | 34 |
2024 June | 43 | 2 | 45 |
2024 May | 30 | 9 | 39 |
2024 April | 33 | 6 | 39 |
2024 March | 36 | 10 | 46 |
2024 February | 31 | 7 | 38 |
2024 January | 29 | 1 | 30 |
2023 December | 67 | 9 | 76 |
2023 November | 54 | 46 | 100 |
2023 October | 66 | 27 | 93 |
2023 September | 39 | 14 | 53 |
2023 August | 28 | 11 | 39 |
2023 July | 55 | 13 | 68 |
2023 June | 73 | 11 | 84 |
2023 May | 81 | 14 | 95 |
2023 April | 77 | 5 | 82 |
2023 March | 78 | 10 | 88 |
2023 February | 57 | 14 | 71 |
2023 January | 71 | 6 | 77 |
2022 December | 89 | 13 | 102 |
2022 November | 93 | 26 | 119 |
2022 October | 67 | 12 | 79 |
2022 September | 61 | 14 | 75 |
2022 August | 82 | 18 | 100 |
2022 July | 66 | 24 | 90 |
2022 June | 70 | 18 | 88 |
2022 May | 103 | 13 | 116 |
2022 April | 96 | 13 | 109 |
2022 March | 98 | 8 | 106 |
2022 February | 74 | 14 | 88 |
2022 January | 127 | 12 | 139 |
2021 December | 94 | 24 | 118 |
2021 November | 82 | 17 | 99 |
2021 October | 117 | 23 | 140 |
2021 September | 77 | 15 | 92 |
2021 August | 83 | 20 | 103 |
2021 July | 72 | 12 | 84 |
2021 June | 81 | 18 | 99 |
2021 May | 103 | 23 | 126 |
2021 April | 128 | 25 | 153 |
2021 March | 96 | 5 | 101 |
2021 February | 57 | 9 | 66 |
2021 January | 78 | 12 | 90 |
2020 December | 71 | 17 | 88 |
2020 November | 72 | 16 | 88 |
2020 October | 39 | 8 | 47 |
2020 September | 56 | 13 | 69 |
2020 August | 61 | 11 | 72 |
2020 July | 36 | 16 | 52 |
2020 June | 53 | 7 | 60 |
2020 May | 80 | 27 | 107 |
2020 April | 32 | 9 | 41 |
2020 March | 59 | 16 | 75 |
2020 February | 54 | 5 | 59 |
2020 January | 47 | 10 | 57 |
2019 December | 80 | 7 | 87 |
2019 November | 32 | 17 | 49 |
2019 October | 40 | 7 | 47 |
2019 September | 66 | 17 | 83 |
2019 August | 26 | 5 | 31 |
2019 July | 39 | 10 | 49 |
2019 June | 106 | 33 | 139 |
2019 May | 197 | 70 | 267 |
2019 April | 92 | 33 | 125 |
2019 March | 24 | 12 | 36 |
2019 February | 47 | 16 | 63 |
2019 January | 20 | 6 | 26 |
2018 December | 20 | 5 | 25 |
2018 November | 38 | 11 | 49 |
2018 October | 38 | 5 | 43 |
2018 September | 9 | 10 | 19 |
2018 August | 21 | 5 | 26 |
2018 July | 17 | 7 | 24 |
2018 June | 22 | 5 | 27 |
2018 May | 26 | 6 | 32 |
2018 April | 12 | 3 | 15 |
2018 March | 20 | 2 | 22 |
2018 February | 6 | 3 | 9 |
2018 January | 10 | 2 | 12 |
2017 December | 25 | 3 | 28 |
2017 November | 19 | 4 | 23 |
2017 October | 27 | 5 | 32 |
2017 September | 26 | 10 | 36 |
2017 August | 5 | 8 | 13 |